Polynucleotides encoding engineered ketoreductase polypeptides
AssigneeCodexis, Inc.
InventorsChristopher Savile, John M. Gruber, Emily Mundorff, Gjalt W. Huisman, Steven J. Collier
Life of this patent
Estimating the term…
Abstract
The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds. The engineered ketoreductase polypeptides are optimized for catalyzing the conversion of N-methyl-3-keto-3-(2-thienyl)-1-propanamine to (S)—N-methyl-3-hydroxy-3-(2-thienyl)-1-propanamine.
Claims25
A ketoreductase polypeptide capable of converting substrate N-methyl-3-keto-3-(2-thienyl)-1-propanamine to product (S)—N-methyl-3-hydroxy-3- (2-thienyl)-1-propanamine at a rate that is improved over a reference polypeptide having the amino acid sequence of SEQ ID NO:
- 6, wherein the polypeptide has an amino acid sequence that is at least about 90% identical to a reference sequence based on SEQ ID NO:2, comprising a substitution at position 199, wherein the residue corresponding to residue X46 is arginine;
- residue X60 is isoleucine;
- residue X64 is valine;
- residue X108 is histidine;
- residue 152 is asparagine;
- residue X153 is valine;
- residue X157 is serine;
- residue X198 is asparagine;
- residue X199 is aspartic acid, valine, arginine, or phenylalanine;
- and/or residue X245 is isoleucine.
Dependencies are inferred from the claim text.